Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a small maintenance update to the site without altering the study details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, signaling a minor backend/template update to the page. This does not change the study details or user-facing content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the page rendering. This reflects a maintenance update without changes to the study content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer now displays Revision: v3.6.3, indicating a minor platform update to the site. This update does not modify the study details or results.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a backend update rather than changes to the displayed study details.SummaryDifference0.1%

- Check90 days agoChange DetectedEnrollment status now shows 'No longer looking for participants' and several user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The 'Intervention/Treatment' heading was reformatted and a site revision note 'Revision: v3.6.0' was included.SummaryDifference0.5%

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.